Impact of Platelet Concentration in PRP on TMJ Subluxation
PRPTMJ
Effect of Platelet Concentration in Platelet-Rich Plasma on Prolotherapy Outcomes in Temporomandibular Joint Subluxation: A Double-Blinded Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
This study is about a treatment for a jaw condition called temporomandibular joint (TMJ) subluxation. In this condition, the jaw can move too far forward during mouth opening, which may cause repeated jaw locking and problems with normal function. The treatment being studied is platelet-rich plasma (PRP) injections. PRP is made from a person's own blood and may help improve joint stability and reduce symptoms. In this study, 40 adults with TMJ subluxation were randomly assigned to receive PRP with either a lower or higher platelet concentration. Each participant received 2 injections, given 2 weeks apart. The study measured jaw pain, how often locking happened, mouth opening, and joint clicking before treatment, after 6 months, and after 5 years. The goal of this study is to find out whether the amount of platelets in PRP changes how well this treatment works.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 2, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedApril 16, 2026
April 1, 2026
9 months
April 2, 2026
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
TMJ Pain on Function
Pain during jaw function measured using a visual analog scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates worst pain.
Baseline, 6 months, and 5 years
Frequency of TMJ locking
Frequency of locking, expressed as number of episodes per day
Baseline, 6 months, and 5 years
Secondary Outcomes (2)
Maximum mouth opening (MMO)
Baseline, 6 months, and 5 years
Presence of joint clicking
Baseline, 6 months, and 5 years
Study Arms (2)
Low Platelet Concentration PRP (L-PRP)
ACTIVE COMPARATORPatients received prolotherapy using platelet-rich plasma with low platelet concentration.
High Platelet Concentration PRP (H-PRP)
ACTIVE COMPARATORPatients received prolotherapy using platelet-rich plasma with high platelet concentration.
Interventions
Intra-articular and pericapsular injection of platelet-rich plasma prepared with Low platelet concentration..
Intra-articular and pericapsular injection of platelet-rich plasma prepared with high platelet concentration.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IBB Universitylead
Study Sites (1)
Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hamida Refai, PhD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors were blinded to group allocation. The clinician performing the intervention was not blinded due to the nature of the procedure.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Prosthodontics
Study Record Dates
First Submitted
April 2, 2026
First Posted
April 16, 2026
Study Start
April 1, 2016
Primary Completion
January 1, 2017
Study Completion
July 1, 2017
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to institutional regulations and ethical considerations regarding patient confidentiality and data protection.